Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br. 2003;85:469-477.
Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital - a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007;8:60.
Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000;6:1157-1162.
Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767-774.
van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717-725.
Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28:427-431.
Au-Yong IT, Wildin CJ, Dias JJ, et al. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg. 2005;9:178-187.
Searle AE, Logan AM. A mid-term review of the results of dermofasciectomy for Dupuytren's disease. Ann Chir Main Memb Super. 1992;11:375-380.
1. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005;68:424-429.
2. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J. 2005;81:425-428.
3. Tubiana R. Evaluation of deformities in Dupuytren's disease. Ann Chir Main. 1986;5:5-11.
4. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin. 1999;15:53-62.
5. Early PF. Population studies in Dupuytren's contracture. J Bone Joint Surg. 1962;44:602-613.
6. Hueston J. Dupuytren's contracture. Curr Orthop. 1988;2:173-178.
7. Gudmundsson KG, Armgrimsson R, Jonsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scand J Rheumatol. 2001;30:31-34.
8. Muguti GI, Appelt B. Dupuytren's contracture in black Zimbabweans. Cent Afr J Med. 1993;39:129-132.
9. Saboeiro AP, Porkorny JJ, Shehadi SI, et al. Racial distribution of Dupuytren's disease in Department of Veterans Affairs patients. Plast Reconstr Surg. 2000;106:71-75.
10. Mitra A, Goldstein RY. Dupuytren's contracture in the black population: a review. Ann Plast Surg. 1994;32:619-622.
11. Abe Y, Rokkaku T, Ofuchi S, et al. Dupuytren's disease on the radial aspect of the hand: report on 135 hands in Japanese patients. J Hand Surg Br. 2004;29:359-362.
12. Lee LC, Zhang AY, Chong AK, et al. Expression of a novel gene, MafB, in Dupuytren's disease. J Hand Surg Am. 2006;31:211-218.
13. Bayat A, Walter J, Lambe H, et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg. 2005;115:134-141.
14. Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br. 2003;85:469-477.
15. Chammas M, Bousquet P, Renard E, et al. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995;20:109-114.
16. Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg Br. 1984;66:322-325.
17. Geoghegan JM, Forbes J, Clark DI, et al. Dupuytren's disease risk factors. J Hand Surg Br. 2004;29:423-426.
18. Godtfredsen NS, Lucht H, Prescott E, et al. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol. 2004;57:858-863.
19. Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital - a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007;8:60.
20. Arafa M, Noble J, Royle SG, et al. Dupuytren's and epilepsy revisited. J Hand Surg Br. 1992;17:221-224.
21. Bisson MA, McGrouther DA, Mudera V, et al. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg Br. 2003;28:351-356.
22. Freehafer AA, Strong JM. The treatment of Dupuytren's contracture by partial fasciectomy. J Bone Joint Surg Am. 1963;45:1207-1216.
23. Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14:131.
24. Becker GW, Davis TR, The outcome of surgical treatments for primary Dupuytren's disease - a systematic review. J Hand Surg Eur Vol. 2010;35:623-626.
25. Harvey LA, Katalinic OM, Herbert RD, et al. Stretch for the treatment and prevention of contractures. Cochrane Database Syst Rev. 2017;(1):CD007455.
26. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000;6:1157-1162.
27. National Institute for Health Research: Horizon Scanning Centre. Collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture - first line. April 2012. http://www.hsc.nihr.ac.uk/ (last accessed 12 April 2016).
28. Brazzelli M, Cruickshank M, Tassie E, et al. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-202.
29. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767-774.
30. Hurst LC, Badalamente MA, Hentz VR, et al; CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968-979.
31. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010;35:534-539.
32. Bainbridge C, Gerber RA, Szczypa PP, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg. 2012;46:177-183.
33. van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717-725.
34. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28:427-431.
35. Cheng HS, Hung LK, Tse WL, et al. Needle aponeurotomy for Dupuytren's contracture. J Orthop Surg (Hong Kong). 2008;16:88-90.
36. Rowley DI, Couch M, Chesney RB, et al. Assessment of percutaneous fasciotomy in the management of Dupuytren's contracture. J Hand Surg Br. 1984;9:163-164.
37. Colville J. Dupuytren's contracture - the role of fasciotomy. Hand. 1983;15:162-166.
38. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren's contracture. J Hand Surg Br. 1988;13:254-256.
39. Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007;89:189-198.
40. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg Br. 1996;21:797-800.
41. Moermans JP. Segmental aponeurectomy in Dupuytren's disease. J Hand Surg Br. 1991;16:243-254.
42. Townley WA, Baker R, Sheppard N, et al. Dupuytren's contracture unfolded. BMJ. 2006;332:397-400.
43. Au-Yong IT, Wildin CJ, Dias JJ, et al. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg. 2005;9:178-187.
44. Umlas ME, Bischoff RJ, Gelberman RH. Predictors of neurovascular displacement in hands with Dupuytren's contracture. J Hand Surg Br. 1994;19:664-666.
45. McCash CR. The open palm technique in Dupuytren's contracture. Br J Plast Surg. 1964;17:271-280.
46. Kemler MA, Houpt P, van der Horst CM. A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy for Dupuytren's disease. J Hand Surg Eur Vol. 2012;37:733-737.
47. Collis J, Collocott S, Hing W, et al. The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-center, randomized, controlled trial. J Hand Surg Am. 2013;38:1285-1294.e2.
48. McIndoe A, Beare RL. The surgical management of Dupuytren's contracture. Am J Surg. 1958;95:197-203.
49. Zachariae L. Extensive versus limited fasciectomy for Dupuytren's contracture. Scand J Plast Reconstr Surg. 1967;1:150-153.
50. Abe Y, Rokkaku T, Kuniyoshi K, et al. Clinical results of dermofasciectomy for Dupuytren's disease in Japanese patients. J Hand Surg Eur Vol. 2007;32:407-410.
51. Searle AE, Logan AM. A mid-term review of the results of dermofasciectomy for Dupuytren's disease. Ann Chir Main Memb Super. 1992;11:375-380.
52. Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren's contracture. J Hand Surg Am. 1987;12:659-664.
53. Kelly C, Varian J. Dermofasciectomy: a long-term review. Ann Chir Main Memb Super. 1992;11:381-382.
54. Weinzierl G, Flugel M, Geldmacher J. Lack of effectiveness of alternative non-surgical treatment procedures of Dupuytren contracture. Chirurg. 1993;64:492-494.
55. Boyer MI, Gelberman RH. Complications of the operative treatment of Dupuytren's disease. Hand Clin. 1999;15:161-166.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台